baber/WOPTO huggingface dataset:
Patent CS-215098-B2 (CS)
Title: Facility for take-up the yearn
Inventor: ARTZT PETER
IPC: D01H4/40
Filed: 1976-10-06
Abstract: The apparatus for the spinning of staple fibres on an open-end spinning machine contains a draw-off nozzle with an inlet funnel (2) and a running channel (3) made of a ceramic material. So that the nozzle can be used for as large a number of different yarns as possible, the inlet funnel has a trumpet-shaped contact surface, of which the local position in the apparatus is variable as a result of the axial displacement of the draw-off nozzle. <IMAGE>
Patent CS-220768-B2 (CS)
Title: Belt splitting machine
Inventor: TRUTSCHEL WILLI
IPC: B26D1/02
Filed: 1980-10-08
Abstract: A belt-knife splitting-machine has a belt-knife (10) guided in a knife guide (9) which extends across the working width. The knife guide is carried by an upper part (8) mounted on a lower part (7). The lower part is resistent to bending but the upper part consists of sections (11, 12, 13) which are hinged together at (20, 21). The knife guide can be given an appropriate deformation by slightly inclining the sections (11, 13) relatively to the section (12) by means of adjusting devices (22, 23, 24, 25). <IMAGE>
Patent CS-214848-B2 (CS)
Title: Method of the quarry extraction
Inventor: HENRIKSSON SUNE T
IPC: E21C41/26
Filed: 1970-10-29
Abstract: A method of open-pit mining according to which a transport ramp system is provided in a tunnel system outside the open pit and the body of materials which is mined for establishing communication between the surface and the different mining levels.
Patent JP-H0524913-B2 (JP)
IPC: C07D307/93
Filed: 1985-01-10
Abstract: 13-oxabicyclo[10.3.0]pentadecane, a valuable ambergris fragrance, is prepared by reacting cyclododecanone with cyanoacetic acid in the presence of a Knoevenagel catalyst to form cyclododecenylacetonitrile, the nitrile is hydrolyzed to cyclododecenylacetic acid, and the acid is cyclized to the lactone, and the lactone is reduced to the corresponding diol which is cyclized to 13-oxabicyclo[10.3.0]pentadecane.
Patent AU-697976-B2 (AU)
Title: Benzofuran carboxamides and sulphonamides
Inventor: DYKE HAZEL JOAN
IPC: A61K31/443
Filed: 1996-12-05
Granted: 1998-10-22
Abstract: Benzofuran carboxides and sulphonamides have therapeutic utility, e.g. in the treatment of inflammation and asthma, by virtue of their ability to inhibit phosphodiesterases and tumor necrosis factor.
Patent AU-732444-B2 (AU)
Title: Multi-body diameter carrier
Inventor: OLSEN ROBERT
IPC: B65D71/50
Filed: 2000-03-01
Granted: 2001-04-26
Abstract: This invention relates to a carrier (10) for unitizing a plurality of containers (5) wherein a sheet of resilient polymeric material is formed with a plurality of container receiving apertures (20) aligned in opposing transverse pairs so that each container receiving aperture (20) has a small radius defining an apex (25) at an interior edge. A transverse web (30) is formed between each opposing transverse pair of container receiving apertures (20) and an aperture (40) preferably elongate is positioned in the transverse web (30) between the apices (25) of the opposing transverse pairs of container receiving apertures (20). The apertures (40) are preferably sized to permit a small amount of stretch in the transverse web (30) depending upon the diameter and/or contour of the containers resulting in a controlled transverse spacing between containers (5) regardless of their diameter.
Patent AU-644539-B2 (AU)
Title: Imidazoindolizine derivatives and process for preparation thereof
Inventor: HONMA YASUSHI
IPC: A61K31/435
Filed: 1992-09-02
Granted: 1993-12-09
Abstract: An imidazoindolizine derivative of the formula [I]: <CHEM> wherein R<1> is lower alkyl, R<2> is hydrogen, cyano, lower alkyl, lower alkanoyl, lower alkoxycarbonyl, phenyl-lower alkoxycarbonyl, lower alkylsulfonyl, substituted or unsubstituted phenyl, arylcarbonyl, or 5- or 6-membered nitrogen-containing heteromonocyclic group-substituted carbonyl, Ring A is substituted or unsubstituted phenyl, and m is 0 or 1, or a pharmaceutically acceptable salt thereof, and process for preparation thereof, said imidazoindolizine derivatives and pharmaceutically acceptable salts thereof show excellent angiotensin II inhibitory activities and are useful in the prophylaxis or treatment of hypertension.
Patent AU-610243-B2 (AU)
Title: Chemical addition agent and process for its production
Inventor: NAUTA HARRY H K
IPC: C21C7/00
Filed: 1988-09-21
Granted: 1991-05-16
Abstract: Molybdenite is roasted under controlled conditions to provide a polymolybdenum oxide composition having an oxygen content in excess of the stoichiometric oxygen content for MoO2 and less than that for MoO3, such that the composition contains MoO3 equivalent in excess of 5% and ranging up to 15% by weight, preferably, from about 10% to 15% by weight. The polymolybdenum oxide composition can be used to introduce molybdenum into baths of molten steel and the like with high recovery of the molybdenum content in the bath and with quiet addition characteristics as compared to the use of MoO3 per se. Preferably, a Herreshoff type roaster is used and the production rate of the furnace producing the new product is substantially increased, with an exit gas richer in SO2, as compared to use of the same roaster in roasting molybdenite to form MoO3 per se.
Patent AU-701770-B2 (AU)
Title: Fetus fixation enhancer and diet for mother animals
Inventor: YASUI HISAKO
IPC: A23L1/30
Filed: 1995-07-10
Granted: 1999-02-04
Abstract: The safe fetus fixation enhancer to stabilize the intrauterine fixation of a fetus contains a bacterial strain of genus Bifidobacterium having an effect of augmenting IgA production as the effective ingredient. The effect of augmenting IgA production is called IgA induction potential, which potential activates and enhances the action of IgA production cells producing secretory-type IgA against antigen. When the fetus fixation enhancer is administered to a mother animal on pregnancy or on the schedule of pregnancy, the action of the secretory-type IgA augmented and produced in the mother body for preventing infection is exerted to prevent and avoid the adverse effects of infectious diseases possibly causing the deciduation of an embryo or a fetus from the uterine wall, whereby the intrauterine fixation of the fetus can be stabilized.
Patent AU-757237-B2 (AU)
Title: Compositions and methods of treating tumors
Inventor: GREENE MARK I
IPC: A61K38/00
Filed: 1999-03-04
Granted: 2003-02-06
Abstract: Methods of treating an individual who has an  erb B protein mediated tumor is disclosed. Methods of preventing  erb B protein mediated tumors in an individual are disclosed. The methods comprise adminstering to the individual a nucleic acid molecule that encodes a protein that dimerizes with an  erb B protein and that is deficient in tyrosine kinase activity. Composition that comprise such nucleic acid molecules including pharmaceutical compositions are disclosed.
Patent AU-768722-B2 (AU)
Title: Overrun water ice with antifreeze protein
Inventor: DANIEL ADRIAN
IPC: A23G9/32
Filed: 2000-03-02
Granted: 2004-01-08
Abstract: An ice confection comprising an antifreeze protein, wherein  DELTA  modulus/original modulus ≥ 0.4, and/or A strength/original strength ≥ 0.4; providing that when  DELTA  modulus/original modulus ≤ 6.0,  DELTA  modulus ≥ 50MPa, and/or when  DELTA  strength/original strength ≤ 2.0, A strength ≥ 0.2MPa. <??>Such ice confections have a strong, close-packed continuous network of ice crystals and can be used to manufacture products having novel textures, properties and/or shapes.
Patent AU-681338-B2 (AU)
Title: Sex steroid activity inhibitors
Inventor: LABRIE FERNAND
IPC: A61P17/08
Filed: 1992-12-01
Granted: 1997-08-28
Abstract: Inhibitors of sex steroid activity, for example those having the general structure   <IMAGE>   may be used as part of a pharmaceutical composition to provide antiestrogenic effects and/or to suppress estrogen synthesis. Such pharmaceutical compositions are useful for the treatment of breast cancer or other diseases whose progress is aided by activation of sex steroid receptors.
Patent AU-770588-B2 (AU)
Title: A device forming a moving handrail for an accelerated moving walkway
Inventor: FRANCESCHI JEAN CLAUDE
IPC: B66B23/26
Filed: 2000-04-26
Granted: 2004-02-26
Abstract: Guiding rail (10) carries counter-carriages (9) linked to each other with supple links (6), and approaching carriage-bearing rail (4) of handrail in zone (D) situated between spacing zone (B), and turnaround zone (F). Guiding rail follows cam contour with profile having each wave length (B1) equals to distance between first and third counter-carriages placed on either end of encirc wave.
Patent AU-723075-B2 (AU)
Title: Folding blinds for windows and doors
Inventor: CITTADINI ANTONIO
IPC: E06B9/58
Filed: 1997-05-27
Granted: 2000-08-17
Abstract: This invention relates to folding blinds for windows and doors, comprising a number of horizontally articulated slats connected to each other by means of hinged joints which, when the blind is raised, enable the slats to automatically fold like an accordion inside a box. Each slat features a pin terminating with a wheel, which is engaged by the teeth of two cams whose rotation allows the raising and lowering of the blind.
Patent AU-756940-B2 (AU)
Title: Phosphonic acid diester derivatives
Inventor: SAKAI YASUHIRO
IPC: A61P3/10
Filed: 1999-04-21
Granted: 2003-01-30
Abstract: Novel phosphonic diester derivatives represented by general formula (1) or pharmacologically acceptable salts thereof which are useful as drugs, wherein R<1> represents amino, N-(lower alkyl)amino, N-(lower alkenyl)amino, etc.; R<2> and R<3> represent each hydrogen, lower alkyl, halogeno, lower alkoxy etc.; R<4> represents hydrogen, lower alkyl or phenyl(lower alkyl); R<5> and R<6> represent each lower alkyl; X, Y and Z are all carbon atoms, or one of X, Y and Z is a nitrogen atom while other two are carbon atoms; and Q represents a single bond or alkylene.
Patent AU-633490-B2 (AU)
Title: Reduced calorie peanut butter
IPC: A23L25/00
Filed: 1989-06-29
Granted: 1993-02-04
Abstract: The present invention relates to a reduced calorie peanut butter wherein the oil phase comprises triglycerides containing at least about 10% by weight medium chain fatty acids. Preferably, medium chain triglycerides are used in the oil phase. It has been found that use of these triglycerides allows the desired peanut butter consistency to be maintained at lower levels of total oil.
Patent AU-631131-B2 (AU)
Title: Lactam derivatives
IPC: C07D487/04
Filed: 1989-08-01
Granted: 1992-11-19
Abstract: The invention relates to tricyclic lactams of the general formula (I)   <CHEM>  wherein Im represents an imidazolyl group of the formula: <CHEM> and R<1> represents a hydrogen atom or a group selected from C1-6alkyl, C3-6alkenyl, C3-10alkynyl, C3-7cycloalkyl, C3-7cycloalkylC1-4alkyl-, phenyl, phenylC1-3alkyl-, -CO2R<5>, -COR<5>, -CONR<5>R<6> or -SO2R<5> (wherein R<5> and R<6>, which may be the same or different, each represents a hydrogen atom, a C1-6alkyl or C3-7cycloalkyl group, or a phenyl or phenylC1-4alkyl- group, in which the phenyl group is optionally substituted by one or more C1-4alkyl, C1-4alkoxy or hydroxy groups or halogen atoms, with the proviso that R<5> does not represent a hydrogen atom when R<1> represents a group -CO2R<5> or -SO2R<5>); one of the groups represented by R<2>, R<3> and R<4> is a hydrogen atom or a C1-6alkyl, C3-7cycloalkyl, C3-6alkenyl, phenyl or phenylC1-3alkyl- group, and each of the other two groups, which may be the same or different, represents a hydrogen atom or a C1-6alkyl group;  Y represents the group CH=CH or (CH2)n, wherein n represents 2 or 3; Q represents a halogen atom, or a group selected from hydroxy, C1-4alkoxy, phenylC1-3alkoxy-, C1-6alkyl, cyano, phenyl which may be unsubstituted or substituted by one or more C1-4alkyl, C1-4alkoxy or hydroxy groups or halogen atoms, -NR<7>R<8>, -CONR<7>R<8> or -(CH2)pCONR<7>R<8> (wherein R<7> and R<8>, which may be the same of different, each represents a hydrogen atom or a C1-4alkyl or C3-4alkenyl group, or together with the nitrogen atom to which they are attached form a saturated 5 to 7 membered ring; and p represents 1,2 or 3), -(CH2)qNR<9>R<1><0> (wherein R<9> represents a hydrogen atom or a C1-4alkyl group, and R<1><0> represents a group -COR<1><1> or -SO2R<1><1> wherein R<1><1> represents a C1-4alkyl group; and q represents 0, 1, 2 or 3), or -(CH2)2CO2R<1><1>(R<1><1> being as defined previously);  Q min  represents a hydrogen or a fluorine atom;  and physiologically acceptable salts and solvates thereof. The compounds are potent and selective antagonists of the effect of 5-HT at 5-HT3 receptors and are useful, for example, in the treatment of psychotic disorders, anxiety, and nausea and vomiting.
Patent AU-762405-B2 (AU)
Title: Treatment of papilloma virus infection using a mycobacterium
Inventor: BOHLE ANDREAS
IPC: A61K35/74
Filed: 1999-04-29
Granted: 2003-06-26
Abstract: Disease cased by papilloma virus is treated by applying an effective amount of Mycobacterium to the region of infection. Specifically, condylomata acuminata are caused by human papilloma virus infection. Despite numerous treatment modalities these patients often demonstrate recurrent disease. BCG therapy is used in primary treatment or in patients not responding to or recurrent after standard treatment. Six men with rapidly recurrent external and intraurethral condylomata acuminata underwent BCG therapy after initial laser treatment. External application and intraurethral instillation of BCG was performed six times in weekly intervals. Follow-up studies included examination and endoscopic inspection of the urethra and bladder. Three patients completed one course of BCG and had no relapse of condylomata acuminata. Two patients underwent a second course of BCG, of whom one relapsed. One patient relapsed after discontinued therapy due to penile edema. The annual recurrence rate decreased from 3.2 before the BCG therapy to 0.75 after BCG therapy (p<0.05, test of equality of 2 percentages). In addition, eight men underwent BCG therapy as primary therapy without initial laser treatment, following the same course of treatment, but employing BCG in a cream with salicylic acid to promote keratolysis. Six out of eight patients completely recovered. The BCG-induced immune response appears to reduce the recurrence rate in patients with condylomata acuminata.
Patent AU-620912-B2 (AU)
Title: Using cocoa powder to enhance the flavor of mint flavored chewing gum
Inventor: DAVE JAYANT C
IPC: A23G4/06
Filed: 1989-08-28
Granted: 1992-02-27
Abstract: The present invention includes a method of enhancing the flavor of a mint flavored chewing gum by the addition of a minor amount of cocoa powder, as well as the chewing gum so produced. The amount of cocoa powder is selected so as to cause the flavor enhancement and so as to not impart a detectable chocolate flavor to the chewing gum. The level of cocoa powder added is between about 0.08 and 0.5 percent by weight of the chewing gum.
Patent AU-776709-B2 (AU)
Title: Treatment method for making heat exchanger hydrophilic and heat exchanger treated to be hydrophilic
Inventor: KOJIMA MASAHIRO
IPC: C11D7/10
Filed: 2001-05-11
Granted: 2004-09-16
Abstract: A treatment method for hydrophilicity for a heat exchanger which can maintain the deodorizing property and hydrohilicity even after a long-time use, and a heat exchanger thus treated for hydrophilicity by said method are provided. After a previous acidic washing treatment, a heat exchanger is subjected to a chemical transformation treatment to form a chemical conversion coating film using a chromium chromate treatment agent, chromium phosphate treatment agent, or treatment agent of zirconium series, followed by a treatment for hydrophilicity using a treatment agent for hydrophilicity, which contains silica particulates and polymer of vinyl alcohol series in aqueous medium in a weight ratio 30:70 SIMILAR 70:30 and in tot al content of 1 SIMILAR 25 weight percent, and in which said silica particulates are coated with said polymer of vinyl alcohol series, and dispersed as coated particles of the average particle diameter of 5 SIMILAR 1000 nm in aqueous medium, to form the coating film so as to amount to 1 SIMILAR 3 g/m<2>.
Patent AU-780444-B2 (AU)
Title: Chlamydia antigens and corresponding DNA fragments and uses thereof
Inventor: MURDIN ANDREW D
IPC: A61P31/04
Filed: 2000-05-03
Granted: 2005-03-24
Abstract: The present invention provides vaccines for immunizing a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine and method employ a full-length, 5'-truncated or 3'-truncated 76 kDa protein of a strain of Chlamydia pneumoniae. Modifications are possible within the scope of this invention.
Patent AU-577878-B2 (AU)
Title: Non spring opening of frangible member
Inventor: HOFT PETER
IPC: B65D17/40
Filed: 1985-07-23
Granted: 1988-10-06
Abstract: There is provided a tin lid for flat cans rounded oblong, in Hansa format, which includes in its lid image section, a tear-open portion defined by a self-contained notch line capable of being broken up at one end of the lid by means of a pull-open ring attached to this end. At the other end, said notch line includes a straight-lined notch line section which extends in chordal-type fashion with respect to the core wall shaped like an arc of a circle and which is arranged perpendicular and symmetrically to the longitudinal lid center line and which is connected with the other portions of the notch line through a polygonal or chordal-type connecting notch line. The distance between the chordal-type notch line section and the core wall, measured along the longitudinal center line of the lid, preferably ranges between 6 and 10 mm.
Patent AU-676184-B2 (AU)
Title: Antiproliferative oligomers
Inventor: CARDIN ALAN D
IPC: A61K31/795
Filed: 1993-07-16
Granted: 1997-03-06
Abstract: The oligomers of the present invention are polyureas or polyamides having a number average molecular weight of <10,000. These oligomers are water-soluble, have a rigid backbone with a predictable anion spacing, and are pharmaceutically-acceptable. The oligomers are useful for inhibiting the proliferation of smooth muscle cell.
Patent AU-720803-B2 (AU)
Title: New N-benzylpiperazine compounds, process for their preparation and the pharmaceutical compositions which contain them
Inventor: WIERZBICKI MICHEL
IPC: A61K31/44
Filed: 1997-12-16
Granted: 2000-06-15
Abstract: N-benzyl piperazine derivatives of formula (I), their isomers and addition salts with acids and bases are new. R1 = 1-6 C alkyl; X = O or S; R2 = 1-8 C alkyl (optionally substituted by CO2H or 1-6C alkoxycarbonyl), 1-6C alkoxy, phenyl (optionally substituted by halo, 1-6C alkyl or alkoxy, OH or trihalomethyl), 3-7C cycloalkyl (optionally substituted by ≥ 1 phenyl (optionally substituted by ≥ 1 halo or 1-6C alkyl or alkoxy, OH or trihalomethyl)), 4-(2,3-dithiacyclopent-1-yl)-butyl, pyridyl, NH2 (optionally mono- or di-alkylated with 1-6C alkyl), or a chroman or chroman-alkyl group; and R3 = H, 3-7C cycloalkyl, CHO, phenyl (optionally substituted by halo, 1-6C alkyl or alkoxy, OH or trihalomethyl), pyridyl or 1-20 C alkyl (optionally substituted by ≥ 1 halo, phenyl or cycloalkyl (optionally substituted as described above as in R2)), 1-6C alkoxy, OH or pyrrolidinyl.
Patent AU-775847-B2 (AU)
Title: Modular building system
Inventor: CROWELL JAMES H
IPC: E04B1/08
Filed: 2000-05-10
Granted: 2004-08-19
Abstract: A modular building system (100) including preformed extrusion-molded polymeric material (116). Parts include integral connector elements (160, 162) which can be slidably and snappingly reversibly interconnected to form the basic frame (102) and panel structures (108) of an overall building. The interconnected region permits limited ranges of angular as well as translational relative motion between adjacent, connected elements. Parts are assembled simply and quickly in the field, without requiring skilled labor or specialized tools, to form a functionally solid and stable building which responds to loads and temperature changes with yieldable, accommodating deformations that minimize the likelihood of building structural damage, and effectively transmit necessary loads to the ground via load-transfer paths through the building.
Patent AU-777117-B2 (AU)
Title: Immunoassay for measuring human C-peptide and kit therefor
Inventor: KITAJIMA SACHIKO
IPC: G01N33/74
Filed: 2001-06-12
Granted: 2004-09-30
Abstract: An immunoassay for selectively measuring human C-peptide as well as a kit therefor is disclosed. In the method, human C-peptide contained in a sample, a first anti-human C-peptide antibody, and a second anti-human C-peptide antibody which is immobilized on a solid support are reacted to form an immune complex among these three components. The formed immune complex is separated from the non-reacted antibodies and sample; and then the separated immune complex is quantified. The first antibody recognizes an epitope existing in the region from 1st to 10th amino acid residue from the N-terminal of the human C-peptide, and the second antibody recognizes an epitope existing in the region from 1st to 16th amino acid residue from the N-terminal of human C-peptide; with the proviso that the first and second antibodies do not recognize the same epitope so that they can simultaneously bind to said human C-peptide. <IMAGE>
Patent AU-707708-B2 (AU)
Title: Dust-free hole cutting method and apparatus
Inventor: TILLEMANS GREGORY M
IPC: B23Q11/00
Filed: 1996-04-11
Granted: 1999-07-15
Abstract: A vacuum template has a suction chamber on its back surface that adheres the template to the wall or other flat surface when a source of vacuum pressure attached to the template is turned on and the template has been placed by the worker in its desired position. Dust inlets adjacent a guidance hole in the template immediately suction away dust particles as the hole is being cut by a power tool or hand saw manipulated by the user. Interchangeable modules on the template provide for variations in hole size and shape.
Patent AU-591392-B2 (AU)
Title: Having corrosion protective device for insulator cap thereof
Inventor: DECKER DANIEL DE
IPC: H01B17/42
Filed: 1986-04-14
Granted: 1989-11-30
Abstract: An electrical insulator (1) of the type comprising at least one dielectric (2) and an iron or steel cap (3) fixed axially on the dielectric has a device for protecting the cap against corrosion as well as electric arcs. In one embodiment (FIGS. 1-3), the protection device comprises a zinc or aluminum part (10) shaped as a dish with a center hole (11) and outlet holes (12) for the egress of rainwater. The outside wall (13) of the part (10) curves upwardly toward the cap (3) and a portion of the part (10) is disposed between the base (6) of the cap (3) and the outer surface (7) of the dielectric (2). In another embodiment (FIG. 4), the protection device comprises a solid body of revolution (30) of semi-toroidal shape which is formed of zinc or aluminum and is cast directly around the base (6) of the cap (3) and has a thin flange extending between the base (6 )of the cap (3) and the outer surface (7) of the dielectric (2). The exterior surface (31) of the solid body of revolution (30) curves upwardly so as to provide between such exterior surface and the outer surface (7) of the dielectric (2) an area for the self-extinguishing of electric arcs.